Lupus eritematoso neonatal / Neonatal lupus erythematosus
Acta pediatr. esp
; 63(7): 276-278, jul.-ago. 2005. ilus, tab
Article
in Es
| IBECS
| ID: ibc-040531
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
El lupus eritematoso neonatal es un cuadro producido por el paso transplacentario de anticuerpos anti-SSA/Ro o anti-SSB/La de la madre al feto. Se caracteriza, fundamentalmente, por lesiones cutáneas y/o cardiacas. Las lesiones cutáneas tienden a desaparecer mientras el lactante va eliminando los anticuerpos maternos, pero las cardiacas, en caso de producirse, se manifiestan como bloqueo cardiaco congénito que puede requerir la implantación de un marcapasos. Las lesiones cutáneas aisladas no requieren tratamiento. Los sucesivos embarazos deben monitorizarse de forma asidua por el alto riesgo de recurrencia
ABSTRACT
Neonatal lupus erythematosus is produced by the transplacental passage of anti-SSA/Ro or anti-SSB/La antibodies from the mother to the fetus. It is mainly characterized by skin and/or cardiac lesions. The skin lesions tend to disappear as the infant eliminates the maternal antibodies, but the cardiac damage, when it develops, presents as congenital heart block which may require a pacemaker. The isolated skin lesions need no treatment. Subsequent pregnancies should be closely monitored due to the high risk of recurrence
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
IBECS
Main subject:
Lupus Erythematosus, Cutaneous
/
Sjogren's Syndrome
/
Soft Tissue Injuries
Type of study:
Etiology study
Limits:
Child
/
Female
/
Humans
/
Infant
/
Male
Language:
Spanish
Journal:
Acta pediatr. esp
Year:
2005
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario Gregorio Marañón/España